About Intellectual Property IP Training IP Outreach IP for… IP and... IP in... Patent & Technology Information Trademark Information Industrial Design Information Geographical Indication Information Plant Variety Information (UPOV) IP Laws, Treaties & Judgements IP Resources IP Reports Patent Protection Trademark Protection Industrial Design Protection Geographical Indication Protection Plant Variety Protection (UPOV) IP Dispute Resolution IP Office Business Solutions Paying for IP Services Negotiation & Decision-Making Development Cooperation Innovation Support Public-Private Partnerships The Organization Working with WIPO Accountability Patents Trademarks Industrial Designs Geographical Indications Copyright Trade Secrets WIPO Academy Workshops & Seminars World IP Day WIPO Magazine Raising Awareness Case Studies & Success Stories IP News WIPO Awards Business Universities Indigenous Peoples Judiciaries Genetic Resources, Traditional Knowledge and Traditional Cultural Expressions Economics Gender Equality Global Health Climate Change Competition Policy Sustainable Development Goals Enforcement Frontier Technologies Mobile Applications Sports Tourism PATENTSCOPE Patent Analytics International Patent Classification ARDI – Research for Innovation ASPI – Specialized Patent Information Global Brand Database Madrid Monitor Article 6ter Express Database Nice Classification Vienna Classification Global Design Database International Designs Bulletin Hague Express Database Locarno Classification Lisbon Express Database Global Brand Database for GIs PLUTO Plant Variety Database GENIE Database WIPO-Administered Treaties WIPO Lex - IP Laws, Treaties & Judgments WIPO Standards IP Statistics WIPO Pearl (Terminology) WIPO Publications Country IP Profiles WIPO Knowledge Center WIPO Technology Trends Global Innovation Index World Intellectual Property Report PCT – The International Patent System ePCT Budapest – The International Microorganism Deposit System Madrid – The International Trademark System eMadrid Article 6ter (armorial bearings, flags, state emblems) Hague – The International Design System eHague Lisbon – The International System of Appellations of Origin and Geographical Indications eLisbon UPOV PRISMA Mediation Arbitration Expert Determination Domain Name Disputes Centralized Access to Search and Examination (CASE) Digital Access Service (DAS) WIPO Pay Current Account at WIPO WIPO Assemblies Standing Committees Calendar of Meetings WIPO Official Documents Development Agenda Technical Assistance IP Training Institutions COVID-19 Support National IP Strategies Policy & Legislative Advice Cooperation Hub Technology and Innovation Support Centers (TISC) Technology Transfer Inventor Assistance Program WIPO GREEN WIPO's Pat-INFORMED Accessible Books Consortium WIPO for Creators WIPO ALERT Member States Observers Director General Activities by Unit External Offices Job Vacancies Procurement Results & Budget Financial Reporting Oversight

[process2-comments] RFC-3

Note: Submission received post-Report, on December 3, 2001.

 

Mr. Francis Gurry
WORLD INTELLECTUAL PROPERTY ORGANIZATION
34 chemin des Colombettes, P.O. Box 18, 1211
Geneva 20, Switzerland

3 December 2001

 

Dear Mr. Gurry,

We are writing on behalf of our client, ANAKENA PHARMA MARKETING, S.L. ("ANAKENA"), a company devoted to promoting information about generic drugs.

The purpose of this letter is to inform you that Annex II of the Report of the Second Internet Domain Name Process contains inaccurate information. According to the text of Annex II, the World Health Organization (WHO) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) submitted the information that is published as Annex II of the Report.

The above referred Annex lists some examples of INNs registered as domain names, as well as the registrant of each such domain name. In this respect, please note that Mr. Andrivet is not the registrant of the domain names that are attributed to him, as the registrant since January 2001 is ANAKENA. We request that such Annex be modified accordingly.

Furthermore, we would like to bring your attention to the fact that Annex II does not barely include any domain names (consisting of INNs) which are registered by pharmaceutical or cosmetic companies. In this sense, we attach to this letter as Exhibit II a list of examples. We understand that, in order to avoid misunderstandings, Annex II of the Report should be as

accurate and complete as possible, and therefore we request that said Annex is completed with the information we provide in Exhibit I to this letter.

Yours sincerely,
Maria Luisa Osuna

Examples of INSS´s registered as domain names:

Domain Name

Registration Holder

Acarbose.com

Bayer AG

Alprazolam.com

Pharmacia AB

Ampicillin.com

DSM NV

Aprotinin.com

Intergen Company

Astemizole.com

Johnson & Johnson

Bambuterol.com

Zeneca Ltd

Bicalutamide.com

Zececa

Bisoprolol.com

Merck NgaA

Bupivacaine.com

Purdue Phama LP

Candesartan.com

AstraZeneca AB

Cefixime.com

American Home Products Corporation

Ceftriaxone.com

F.Hoffmann-La Roche AG

Cetirizine.com

UCB SA

Ciprofloxacine (Cipro)

Bayer AG

Clonazepam.com

Mylan Laboratories Inc.

Clotrimazole.com

Schering-Plough

Cyclosporine.com

Novartis AG

Cyclosporine.net

Novartis AG

Desonide.com

Diosynth B.V. (Akzo Nobel)

Dexfenfluramine.com

Biofarma (Servier)

Diazepam.com

F.Hoffmann-La Roche AG

Docetaxel.com

Aventis

Drotrecogin.com

Eli Lilly and Company

Epoetin.com

Amgen Inc

Esomeprazole.com

Zeneca Ltd.

Etidocaine.com

AstraZeneca AB

Fentanyl.com

Johnson & Johnson

Filgrastim.com

Amgen Inc.

Fluoxetine.net

Eli Lilly

Fomivirsen.com

Novartis AG

Fondaparinux.com

Sanofi-Synthelabo

Formoterol.com

Novartis AG

Fumagiline.com

Sanofi-Synthelabo

Gabapentin.com

Pfizer

Haloperidol.com

Johnson & Johnson

Hydrochlorothiazide.com

AstraZeneca Pharmaceuticals

Hydrocondone.com

Purdue Pharma L.P.

Indapamide.com

Biofarma, S.A.

Isosorbide.com

AstraZeneca Pharmaceuticals

Itraconazole.com

Johnson & Johnson

Lisinopril.net

Zeneca Limited

Mepivacaine.com

Astra Zeneca AB

Meropenen.com

AstraZeneca L.P

Metoprolol.net

Astra Zeneca

Nifedipine.com

Bayer AG

Nisoldipine.com

AstraZeneca Pharmaceuticals

Olanzapine.net

Eli Lilly

Oxycodone.com

Purdue Pharma

Oxycodone.net

Roxane Laboratories, Inc

Paracetamol.com

Roche

Pravastatin.com

Sankyo Pharma GmbH

Praziquantel.com

Novartis AG

Pregabalin.com

Warner-Lambert Company

Prilocaine.com

AstraZeneca AB

Primidone.com

Zeneca Limited

Propranolol.com

Zeneca Limited

Quetiapine.com

AstraZeneca Pharmaceuticals LP

Raloxifene.com

Eli Lilly and Company

Raltitrexed.com

AstraZeneca L.P

Ramipril.com

Astra AB

Rimonabant.com

Sanofi-Synthelabo

Ropivacaine.com

AstraZeneca AB

Somatropin.com

Pharmacia AB

Tamoxifen.com

Zeneca Limited

Tirapazamine.com

Sanofi-Synthelabo

Tramadol.com

Purdue Pharma L.P

Valdecoxib.com

Pharmacia AB

Vancomycin.com

Pharmacia AB

Verapamil.com

Pharmacia AB

Viloxazine.com

AstraZeneca UK Limited

Xaliprodene.com

Sanofi-Synthelabo

Zafirlukast.com

AstraZeneca Pharmaceuticals LP

Iohexol.com

Hovione SA

Iopamidol.com

Hovione SA

Iopromide.com

Hovione SA

Itraconazole.com

Johnson & Johnson

Montelukast.com

AstraZeneca Pharmaceuticals

Neomycin.com

Pharmacia AB

Stavudine.com

Bristol Myers Squibb Ltd

Troglitazone.com

Sankyo Pharma GmbH

Warfarin.com

Bristol-Myers Squibb